Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Phase 2 5. People and Illness > PBL2 > Flashcards

PBL2 Flashcards

You may prefer our related Brainscape-certified flashcards:
People You Should Know flashcards
1
Q

What is metastasis?

A

spread of a tumour to and growth at ectopic sites via blood, lymphatics, intraepithelial route, or transcoelomic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is invasion?

A

growth by infiltration and destruction of surrounding tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define carcinoma

A

malignant tumour derived from epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Define sarcoma

A

malignant tumour derived from mesenchymal cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Define melanoma

A

malignant tumour derived from neural crest cells (melanocytes)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define leukaemia

A

malignant tumour derived from circulating white blood cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define lymphoma

A

malignant tumour derived from lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the basement membrane?

A

The basement membrane delineates epithelial/endothelial tissues
- a layer of extracellular matrix, made up of fibronectin, type IV collagen and laminin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How is the basement membrane made?

A

It is secreted by basal epithelial cells/endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the significance of the BM in cancer?

A

The basement membrane acts as a primary barrier against the spread of cancerous cells, especially
carcinomas.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the requirements for a cell to metastasise?

A

Neoplastic cells have to develop several attributes in order to metastasise

  • reduced cell-cell adhesion
  • altered cell-substratum adhesion
  • increased motility
  • increased proteolytic ability
  • ability to intravasate and extravasate
  • ability to proliferate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is E-cadherin?

A

(epithelial cadherin) is a a structure that is

used to connect adjacent epithelial cells together.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is e-cadherin’s role in metastasis?

A

Loss of this epithelial adhesion molecule helps to
enable metastasis by disrupting the intercellular
contact, this is an early step in the metastatic
dissemination

E-Cadherin is calcium-dependent. Some tumours
(e.g. diffuse-type gastric tumours), there is ‘exon
skipping’ which is when the axons encoding for the calcium binding domain are missing.

So, for carcinomas and melanomas, the cancer cells acquire the ability to ‘unglue’ via mutations/
epigenetic alterations in E-Cadherin, or in molecules that regulate/interact with it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are integrins?

A

Integrins are cell-surface molecules that bind to

extracellular matrix molecules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where are integrins found?

A

Integrins are found in basal epithelial cells and in focal

adhesions of migrating cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the role of integrins in metastasis?

A

Specific integrins seem to promote invasion & metastasis. Possible mechanisms:
• ↓ Adhesion to the basement membrane surrounding the epithelium
• ↑ Migration through stroma
• ↑ Adhesion to the basement membrane or endothelial cells of blood vessels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is hepatocyte growth factor?

A

HGF or “scatter factor” can induce epithelial cells to
dissociate and scatter in culture

HGF is a mitogen and a motogen (motility factor). It is
produced by the stromal cells in a tumour.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is HGF’s role in metastasis?

A

HGF binds to c-met (a receptor tyrosine kinase).
Activation of c-met leads to ↑ tyrosine phosphorylation of
β-catenin which disrupts E-Cadherin-mediated
adhesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Describe the tumour microenvironment

A

Tumour cells do not act in isolation, but rather subsist in a rich microenvironment provided by:
• Fibroblasts
• Endothelial cells
• Pericytes (cells that wrap around endothelial cells of
blood vessels)
• Leukocytes
• Tumour-associates vasculature.
These secrete various factors including growth factors,
chemokines and enzymes that the tumour stroma can
take advantage of.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe how a neoplastic cell develops increased proteolytic ability

A

The production of proteolytic enzymes that degrade the environment, especially the ECM are important in metastasis e.g. matrix metalloproteinases (MMPs), which degrade type IV collagen in the
basement membrane.

(Other classes of enzymes are serine proteases., e.g. urokinase plasminogen activator (uPA) & plasmin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the function of VEGF?

A

VEGF (Vascular Endothelial Growth Factor)
The VEGF binds to VEGF receptors on nearby endothelial cells, causing the endothelial cells to migrate
towards the tumour and start forming new blood vessels.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the role of VEGF in metastasis?

A

Tumour cells can express VEGF if they are hypoxic i.e. starved of oxygen, creating new vessels

newly forming vessels are weak and leaky, allowing fibrinogen to leak out. This is
converted to fibrin by pro-coagulants released from the TME. The fibrin
forms a clot, which provides a good surface for endothelial to grow onto

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How does a neoplastic cell develop the ability to intravasate and extravasate?

A

thought to exploit abilities of WBCs

Lymphocytes have the ability to intravasate and extravasate due to role in immune surveillance (“lymphocyte homing”)

WBCs transiently bind to endothelial cells via selectin molecules, allowing them to bind and
roll onto endothelial cells and start to intravasate/extravasate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What are the two hypothesis for proliferation?

A

1 - seed and soil

2 - mechanical

25
Q

Describe the seed and soil hypothesis

A

proposed organ-preference patterns of tumour metastasis are the
product of favourable interactions between metastatic tumour cells (the “seed”) and their organ
microenvironment (the “soil”).

26
Q

What is tissue tropism?

A

Preferential growth in different sites

27
Q

What are the possible mechanisms for tissue tropism

A

Selective adhesion to endothelium of target organs (selectins , CD44 variants)
• Selective response to GFs at ectopic site – e.g., PTHRP and IL-11 allow breast cancer cells to establish
osteolytic metastases
• Selective migration to CK source (differential CKR expression)
• Factors released by tumour cells cause changes in microenvironment at secondary sites, creating premetastatic
niche
• Balance of local angiogenic factors versus systemic anti-angiogenic factors (angiostatin & endostatin)

28
Q

What is BRAF?

A

B-Raf is a member of the Raf kinase family which are a family of growth signal transduction protein
kinases

29
Q

What is the normal role of BRAF

A

This protein plays a role in regulating the MAP kinase/ERKs signalling pathway, which affects cell
division, differentiation, and secretion

30
Q

What is BRAFs role in cancer?

A

Approximately 40-60% of melanomas contain a mutation in the oncogene that encodes BRAF that
leads to constitutive activation of downstream signalling in the MAP kinase pathway.

31
Q

What is vemurafenib?

A
  • Drugs attack the BRAF protein directly - Vemurafenib is a reversible, ATP-competitive inhibitor of the kinase domain of BRAF
  • drugs shrink tumours in about half of the people whose metastatic melanoma has a BRAF gene change.
  • can prolong the time before tumours start growing again and help some patients live
    longer, although the melanoma typically starts growing again.
32
Q

What are the three stages of immune surveillance in cancer?

A
  • elimination
  • equilibrium
  • escape
33
Q

Describe the elimination stage of immune surveillance

A

The immune system recognises and
destroys potential tumour cells before they start to
metastasise

34
Q

Describe the equilibrium stage in immune surveillance

A

phase follows when elimination is not entirely successful. During the equilibrium phase, a process known as cancer immunoediting continuously shapes the properties of the tumour cells that survive

35
Q

Describe the escape stage in immune surveillance

A

tumour cells that have accumulated sufficient mutations elude the attentions of the immune system and grow
unimpeded to become clinical detectable

36
Q

What is the principle immune mechanism of tumour eradication?

A
  • killing of tumour cells by cytotoxic T cells (CD8+) specific for tumour antigens
37
Q

How is the cytotoxic T cell response induced?

A

recognition of tumour antigens on host

APCs, which ingest tumour cells or their antigens and present the antigens to T cells via MHC Class 1.

38
Q

What are the current immunotherapeutic approaches to treat diseases?

A
  • cytokine therapy
  • antigen targeted immunotherapy
  • cell based therapies
39
Q

Describe cytokine therapy

A
  • IFN α/β:
    • Interferon α/β is the seen as the ‘gold standard’ for CML (chronic myeloid leukaemia) until imatinib
    was found.
    • It affects MHC Class 1 expression and cell division.
    • It prolongs survival and stabilises disease in cancers such as RCC (renal cell carcinoma).
  • IL-2
    • Therapy of RCC (renal cell carcinoma) and metastatic melanoma
    • Thought to promote expansion of tumour-specific T cells.
40
Q

Describe antigen targeted immunotherapy

A

Pre-formed antibodies (monoclonal antibodies - mab) can target cancel cells directly and mediate
tumour destruction.

Administration of monoclonal antibodies which target either tumour-specific or over-expressed antigens,
or block inhibitor receptors (anti-CTLA4)

41
Q

What are the methods in which monocloncal antibodies can kill tumour cells

A
  • apoptosis induction
  • complement-mediated cytotoxicity
  • Antibody dependent celluylar cytotoxicity
  • Conjugated to toxin/isotope
42
Q

How does ipilimumab work?

A

CD28 is an ‘on-switch’ for CTL’s

CTLA4 is an ‘off-switch’ for CTL’s and is often up regulated by cancer cells

Ipilimumab blocks the CTLA 4 antigen to enhance inflammation and block the immunosuppressive
effects

Ipilimumab also increases the number of active T cells

43
Q

What are the side effects of ipilimumab?

A

But this may also result in loss of some peripheral tolerance, for example, in the gut the CTL’s are
physiologically switched off to prevent them from digesting the gut when faced with a foreign
ingested substance. The MAb may lead to blistering of the gut and other adverse gut responses if
its CTL’s are switched on also.

44
Q

How does nivolumab work?

A

Nivolumab is an anti-PD-L1 monoclonal antibody.

The pathway includes two proteins called programmed death-1 (PD-1), expressed on the surface of immune cells, and programmed death ligand-1 (PD-L1), expressed on
cancer cells.
When PD-1 and PD-L1 join together, they form a
biochemical “shield” protecting tumour cells from being destroyed by
the immune system.

If cells display this, then the PD-1 receptor on the T cell gets activated and it will initiate programmed cell death of the T cell.

However Nivolumab blocks this, and allows the T cell to function

45
Q

What are the different cell based therapies in cancer?

A 
- Haematopoietic Stem cells
• Tumour-Infiltrating T cells (TILs)
• Dendritic Cell Vaccines
• NK cells
• Gamma-delta T cells
• Virus-specific T cells
• Genetically engineered T cells.
46
Q

What is depression?

A

Depression is a common mental disorder characterised by pervasive low mood, anhedonia (inability to
feel pleasure) and low energy.

47
Q

What are the clinical features of depression?

A

Cognitive Features:
• Slowed speed of thought
• Reduced concentration and attention
• Reduced self-esteem and self-confidence
• Ideas of guilt and unworthiness
• Bleak and pessimistic views of the future
• Ideas or acts of self-harm or suicide

Biological Symptoms:
• Sleep disturbance
• Weight loss or gain
• Constipation
• Amenorrhea
• Reduced libido (sex drive)

Psychotic Symptoms:
• Delusions - an idiosyncratic belief or impression maintained despite being contradicted by reality or a
rational argument.
• Hallucinations - hearing or seeing things that aren’t actually there/happening. (Often auditory)

48
Q

What are the biological factors involved in the aetiology of depression

A
  • Genetics
  • Neurochemical theories (dopamine, serotonin, noradrenaline)
  • Neuroendocrine theories (disrupted FPA/HPT axis)
49
Q

What are the psychological factors involved in the aetiology of depression

A
  • Psychodynamic
  • Behavioural
  • Cognitive
  • Arbitrary inference
  • Selective abstraction
  • Magnification
  • Minimisation
  • Overgeneralisation
  • Personalisation
50
Q

What are the socialfactors involved in the aetiology of depression

A
  • Predisposing

- Precipitating

51
Q

How is depression investigated?

A

• Good clinical history, including drug history
• Risk assessment
• Blood tests may include blood glucose, U&Es, LFTs, TFTs, calcium levels, FBC and inflammatory
markers. Other tests may include magnesium levels, HIV or syphilis serology, or drug screening.
• Imaging (MRI or CT brain scanning)

52
Q

What are the biological treatments for depression?

A
  • SSRI
  • TCA
  • SNRI
  • NASSA
  • NRI
53
Q

Give an example of an SSRI and its side effects

A

Fluoxetine

• Nausea, vomiting, agitation, sexual dysfunction, hyponatremia, sweating

54
Q

Give an example of a TCA and its side effects

A

Tricyclic Antidepressants (TCAs)

Amitriptyline

Anticholinergic effects, sedation, weight gain, sweating, hyponatremia, cardiotoxic effects,
hallucinations

55
Q

Give an example of an SNRI and its side effects

A

Serotonin-Noradrenaline Reuptake Inhibitors (SNRIs)

Venlafaxine

nausea, vomiting, agitation, sweating, sexual dysfunction, hypertension

56
Q

Give an example of NASSAs and their side effects

A

Noradrenergic and Specific Serotonergic Antidepressants (NASSAs)

Mirtazepine

• Sedation, weight gain

57
Q

Give an example of NARIs and its side effects

A

Noradrenergic Reuptake Inhibitors (NARIs)

Reboxetine

• Sweating, hypotension, anticholinergic effects

58
Q

What are the psychological managements for depression?

A
  • Behavioural therapy
  • Cognitive therapy
  • Psychotherapy

Phase 2 5. People and Illness (21 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions